Related Experiment Video
Updated: Jul 21, 2025

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Epidemiology of Cryptosporidium Infection in Romania: A Review
Gheorghe Dărăbuș1, Maria Alina Lupu2,3, Narcisa Mederle1
1Discipline of Parasitology, Faculty of Veterinary Medicine, University of Life Sciences King Michael I, 300645 Timisoara, Romania.
Abstract:
Since 1983, when the first report of a human Cryptosporidium spp. infection was published in Romania, and until now, many studies on cryptosporidiosis have been published in our country, but most of them are in the Romanian language and in national journals less accessible to international scientific databases. Although the infection was first recognized as a problem in children or immunocompromised people or more of a problem in low-income or underdeveloped global countries, we have shown in this review that it can also occur in people with normal immunological function and that the epidemiology of our country can provide a theoretical basis for the formulation of a Cryptosporidium spp. prevention strategy. In addition, 9.1% of healthy children and 73% of immunocompromised children were observed to have Cryptosporidium spp. infections. Higher rates have also been reported in immunocompromised adults (1.8-50%). Analyzing the prevalence of Cryptosporidium spp. infection in animals, we found values of 28.52% in cattle, 18% in buffalo calves, between 27.8 and 60.4% in pigs, 52.7% in dogs, and 29.4% in cats. Furthermore, in Romania, the burden of cryptosporidiosis, including acute infections and long-term sequelae, is currently unknown.
Insights
Cryptosporidium infections occur in both healthy and immunocompromised individuals in Romania. This review highlights the parasite
Area of Science:
- Veterinary Medicine
- Human Medicine
- Epidemiology
Background:
- Cryptosporidium spp. infections were first reported in Romania in 1983.
- Most Romanian studies are not accessible internationally.
- Cryptosporidiosis is often associated with immunocompromised individuals and low-income countries.
Purpose of the Study:
- To review the epidemiology of Cryptosporidium spp. in Romania.
- To highlight the occurrence of infections in immunocompetent individuals.
- To provide a basis for a national prevention strategy.
Main Methods:
- Literature review of Romanian studies on Cryptosporidium spp.
Main Results:
- Prevalence in healthy children: 9.1%.
- Prevalence in immunocompromised children: 73%.
- Prevalence in immunocompromised adults: 1.8–50%.
- Animal prevalence: Cattle (28.52%), buffalo calves (18%), pigs (27.8–60.4%), dogs (52.7%), cats (29.4%).
Conclusions:
- Cryptosporidium spp. infections occur in Romania across various populations, including healthy individuals.
- Animal reservoirs are significant.
- The overall burden of cryptosporidiosis in Romania remains unknown.
More Related Videos
07:56Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
12:11A Modified EPA Method 1623 that Uses Tangential Flow Hollow-fiber Ultrafiltration and Heat Dissociation Steps to Detect Waterborne Cryptosporidium and Giardia spp.
Published on: July 9, 2012
Related Concept Videos
Fungal Phylum Microsporidia
Urinary Tract Infection II: Pathophysiology
Diversity of Protists I
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.